Abstract
• Background: The Retinoblastoma International Collaborative Study is a multinational prospective clinical and pathologic registry designed to collect baseline clinical information, data on methods of treatment, and information on the subsequent clinical course of children with retinoblastoma. • Methods: 206 children with newly diagnosed retinoblastoma were evaluated in the participating clinical centers between 1 July 1987 and 31 December 1989. All of the children underwent comprehensive baseline assessment of multiple clinical variables prospectively according to a standard protocol. The recorded values were tabulated and analyzed. • Results: The 206 children with retinoblastoma included 99 boys (48.1%) and 107 girls (51.9%). The mean age at diagnosis was 21.2 mo in the total study group. One hundred twenty-seven of the 206 children (61.7%) had unilateral disease, while 79 (38.3%) had bilateral involvement. The mean age at diagnosis in the bilateral cases (14.6 mo) was substantially less than in the unilateral ones (23.5 mo). The great majority of patients (approximately 75%) had advanced disease (group V in both Reese-Ellsworth and Essen prognosis classifications) in the affected eye (unilateral cases) or the more severely affected eye (bilateral cases). • Conclusions: This study shows that there is a dedicated group of international ophthalmologists and other physicians who are willing to participate in multicenter cooperative clinical studies of retinoblastoma and that a relatively large group of children with this ocular malignancy can be enrolled within this framework during a reasonably short time for the purposes of future studies.
Similar content being viewed by others
References
Messmer EP, Heinrich T, Höpping W, Havers W, Sauerwein W (1991) Classification of metastatic risk in retinoblastoma. In: Bornfeld N, Gragoudas ES, Höpping W, Lommatzsch PK, Wessing A, Zografos L (eds) Tumors of the eye. Kugler, Amsterdam, pp 51–58
Kingston JE, Hungerford JL (1991) The role of chemotherapy in retinoblastoma. In: Bornfeld N, Gragoudas ES, Höpping W, TLommatzsch PK, Wessing A, Zografos L (eds) Tumors of the eye. Kugler, Amsterdam, pp 131–137
Mastrangelo D, Acquaviva A, Di Pisa F, Hadjistilianou T, Frezzotti R (1991) Italian register for retinoblastoma. Pros and cons of a retrospective study. Ophthalmic Paediatr Genet 12:73–78
Minoda K (1983) National registration of retinoblastoma in Japan. In: Lommatzsch PK, Blodi FC (eds) Intraocular tumors. Akademie, Berlin, pp 473–478
The RIGS Planning Group: Augsburger JJ, Giblin ME, Friedberg MA, Meadows AT, Markoe AM (1991) Retinoblastoma International Collaborative Study. In: Bornfeld N, Gragoudas ES, Höpping W, Lommatzsch PK, Wessing A, Zografos L (eds) Tumors of the eye. Kugler, Amsterdam, pp 153–157
Reese AB, Ellsworth RM (1963) The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 67:164–172
Höpping W (1983) The new Essen prognosis classification for conservative sight saving treatment of retinoblastoma. In: Lommatzsch PK, Blodi FC (eds) Intraocular tumors. Akademie, Berlin, pp 497–505
Author information
Authors and Affiliations
Consortia
Additional information
RICS Group Other clinical centers are listed at the end of this manuscript
Rights and permissions
About this article
Cite this article
Augsburger, J.J., Oehlschläger, U., Manzitti, J.E. et al. Multinational clinical and pathologic registry of retinoblastoma. Graefe's Arch Clin Exp Ophthalmol 233, 469–475 (1995). https://doi.org/10.1007/BF00183426
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00183426